BridgeMD
New treatment option for Nutrient Deficiency
Official title Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda
ClinicalTrials.gov ID: NCT06835738
What this study is testing
- What it's testing
- The objective of this research is to understand how antenatal multiple micronutrient supplements (MMS) can be effectively implemented and scaled within the Uganda national health system context to support improved maternal nutrition and birth outcomes. Formative research has been conducted to design the implementation strategies that will be tested in this second phase of the study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 80. Healthy volunteers may be eligible.
You may be able to join if
- for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
- ≤24 weeks of amenorrhea/gestation as verified by health professionals
- Attending first ANC visit at government or PNFP health facilities.
- Accepted to take MMS at first ANC visit
You likely can't join if
- for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
- Pregnant women with pre-existing hematological conditions such as sickle cell anemia, thalassemia, hemochromatosis.
- Pregnant women planning to relocate outside the study district during the study period. Inclusion Criteria for Pregnant women / Women that have...
- Currently pregnant woman or a woman who is not more than 8 weeks postpartum.
- Received MMS at an ANC visit at least 3 months ago or more.
- Attended at least any 2 monthly ANC visits.
See the full eligibility criteria
- for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
- ≤24 weeks of amenorrhea/gestation as verified by health professionals
- Attending first ANC visit at government or PNFP health facilities.
- Accepted to take MMS at first ANC visit
- for Pregnant women- Enrolled for follow-up throughout pregnancy (sample 1)
- Pregnant women with pre-existing hematological conditions such as sickle cell anemia, thalassemia, hemochromatosis.
- Pregnant women planning to relocate outside the study district during the study period. Inclusion Criteria for Pregnant women / Women that have recently delivered (single contact) (sample 2)
- Currently pregnant woman or a woman who is not more than 8 weeks postpartum.
- Received MMS at an ANC visit at least 3 months ago or more.
- Attended at least any 2 monthly ANC visits.
- Attending/attended ANC at government or private-not-for-profit health facility. Exclusion Criteria for Pregnant women / Women that have recently delivered (single contact) (sample 2)
- Enrolled in study population 1.
- Women who are more than 8 weeks postpartum. Inclusion Criteria for ANC providers having ANC health education/counseling with pregnant woman(en) observed (sample 3)
- Healthcare providers that are currently providing ANC health education (group) or ANC individual counseling at government or PNFP health facilities. Exclusion Criteria for ANC providers having ANC health...
- Spouse or partner of a pregnant woman or woman with a child less than 8 weeks old who is receiving/ has received ANC services in one of the 8 study districts.
- Mother or mother-in-law of a pregnant woman or woman with a child less than 8 weeks old who is receiving/ has received ANC services in one of the 8 study districts. Exclusion Criteria for Influential family members...
- Health workers who provide ANC services (e.g., midwives/nurse, medical/ clinical officers, health assistants, and nutrition focal person) at government or private-not-for-profit facilities in one of the 8 study...
- Health facility staff (e.g., Facility In-charge, Maternity In-charge, Pharmacy/Stores In-charge) at government or private-not-for-profit facilities in one of the 8 study districts. Exclusion Criteria for Healthcare...
- None Inclusion Criteria for Community Health Workers (VHTs) and Mentor Mothers (sample 6) Voluntary Health Team (VHT), Mentor Mothers, or Para-socials attached to at least one of the study facilities. Exclusion Criteria...
- National, regional, or district-level decision-makers working in nutrition, maternal, newborn and child health, district health educator or pharmaceutical roles associated with the antenatal care system in Uganda.
- Implementing partners involved in direct implementation of MMS within the 8 study districts Exclusion Criteria for National, regional, and district-level stakeholders (sample 7)
- None Inclusion Criteria for Pregnant women - interviewed during post-intervention Household Coverage Survey (sample 8)
- Woman who has been pregnant or delivered within the study period.
- Household is within one of the 4 selected districts. Exclusion Criteria for Pregnant women - interviewed during post-intervention Household Coverage Survey (sample 8)
- Women who moved to the district after delivery.
The study team makes the final eligibility decision.
Where it's taking place
- Lyantonde, Uganda
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyantonde, Uganda. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.